Name | Percentage of Claims Accepted by Public Drug Programs for Generic Drugs |
Short/Other Names |
Not applicable |
Description | The rate of claims accepted by public drug programs for generic drugs |
Interpretation | This indicator is interpreted as the proportion of utilization that generic drug products account for within public drug programs. |
HSP Framework Dimension |
Health System Inputs and Characteristics: Efficient allocation of resources |
Areas of Need |
Not applicable |
Geographic Coverage |
Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia |
Reporting Level/Disaggregation |
Province/Territory |
Indicator Results |
Identifying Information | |
Name | Percentage of Claims Accepted by Public Drug Programs for Generic Drugs |
Short/Other Names |
Not applicable |
Indicator Description and Calculation | |
Description | The rate of claims accepted by public drug programs for generic drugs |
Calculation: Description | The total number of claims accepted by public drug programs for generic drugs divided by the total number of claims accepted by public drug programs Unit of Analysis: Claims to public drug programs |
Calculation: Geographic Assignment |
Place of residence |
Calculation: Type of Measurement |
Percentage or proportion |
Calculation: Adjustment Applied |
None |
Calculation: Method of Adjustment |
Not applicable |
Denominator |
Description: |
Numerator |
Description: 2. Claims for brand name products |
Background, Interpretation and Benchmarks | |
Rationale |
This indicator measures the uptake of generic drugs on public drug programs. Generic drug products are typically less expensive than brand name products. |
Interpretation |
This indicator is interpreted as the proportion of utilization that generic drug products account for within public drug programs. |
HSP Framework Dimension |
Health System Inputs and Characteristics: Efficient allocation of resources |
Areas of Need |
Not applicable |
Targets/Benchmarks |
Not applicable |
References |
Not applicable |
Availability of Data Sources and Results | |
Data Sources |
NPDUIS Database |
Available Data Years |
Type of Year: |
Geographic Coverage |
Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia |
Reporting Level/Disaggregation |
Province/Territory |
Result Updates | |
Update Frequency |
Whenever required for analytical product or data request |
Indicator Results |
Web Tool: |
Updates |
Not applicable |
Quality Statement | |
Caveats and Limitations |
– Includes only drugs claimed through public drug programs – Excludes any drugs claimed through a private drug plan or purchased over the counter |
Trending Issues |
All data is not available for all years: – Manitoba, Saskatchewan, Alberta, New Brunswick: From January 2000 – Nova Scotia: From April 2001 – Prince Edward Island: From April 2004 – British Columbia: From January 2006 – Newfoundland and Labrador: From April 2008 – Ontario: From April 2010 – First Nations and Inuit Health Branch: From October 2010 |
Comments |
Not applicable |